- Home
- RDHL vs SANW Comparison
RDHL vs SANW Comparison
Compare RDHL & SANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- SANW
- Stock Information
- Founded
- RDHL 2009
- SANW 1980
- Country
- RDHL Israel
- SANW United States
- Employees
- RDHL N/A
- SANW N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- SANW Farming/Seeds/Milling
- Sector
- RDHL Health Care
- SANW Consumer Staples
- Exchange
- RDHL Nasdaq
- SANW Nasdaq
- Market Cap
- RDHL 4.3M
- SANW 4.6M
- IPO Year
- RDHL N/A
- SANW 2010
- Fundamental
- Price
- RDHL $2.18
- SANW $2.41
- Analyst Decision
- RDHL
- SANW Strong Buy
- Analyst Count
- RDHL 0
- SANW 1
- Target Price
- RDHL N/A
- SANW $25.00
- AVG Volume (30 Days)
- RDHL 17.8K
- SANW 102.4K
- Earning Date
- RDHL 08-28-2025
- SANW 05-15-2025
- Dividend Yield
- RDHL N/A
- SANW N/A
- EPS Growth
- RDHL N/A
- SANW N/A
- EPS
- RDHL N/A
- SANW N/A
- Revenue
- RDHL $8,042,999.00
- SANW $54,993,808.00
- Revenue This Year
- RDHL $381.91
- SANW N/A
- Revenue Next Year
- RDHL N/A
- SANW $17.19
- P/E Ratio
- RDHL N/A
- SANW N/A
- Revenue Growth
- RDHL 23.17
- SANW 6.91
- 52 Week Low
- RDHL $1.71
- SANW $1.99
- 52 Week High
- RDHL $20.28
- SANW $11.60
- Technical
- Relative Strength Index (RSI)
- RDHL 65.22
- SANW 30.66
- Support Level
- RDHL $2.00
- SANW $2.00
- Resistance Level
- RDHL $2.08
- SANW $2.58
- Average True Range (ATR)
- RDHL 0.09
- SANW 0.20
- MACD
- RDHL 0.03
- SANW 0.06
- Stochastic Oscillator
- RDHL 97.73
- SANW 70.69
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About SANW S&W Seed Company (NV)
S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.